Literature DB >> 24436943

Successful management of a catecholamine-secreting glomus jugulare tumor with radiosurgery alone.

Jonathan M Fussey1, Andras A Kemeny2, Sailesh Sankar3, Darius Rejali1.   

Abstract

Secretory glomus jugulare tumors are often resected surgically to control the systemic effects of the catecholamines they produce. This involves complex skull base surgery, which carries significant risks and frequent morbidity. Stereotactic radiosurgery (SRS) is a recently recognized treatment for glomus jugulare tumors, though little is known about its use in secretory tumors. Case Report A young fit patient with a catecholamine-secreting glomus jugulare tumor was treated with SRS alone and over the following 37 months her urinary catecholamine excretion fell to near normal levels, and serial magnetic resonance imaging (MRI) confirmed a reduction in tumor volume. Discussion Radiosurgery is an accepted treatment for glomus jugulare tumors and is now readily available to skull base surgeons. In this case a catecholamine-secreting tumor was successfully controlled with radiosurgery alone. Further research and long-term follow-up will determine the role of this treatment in the nonsurgical management of secreting glomus jugulare tumors.

Entities:  

Keywords:  catecholamines; gamma knife; glomus jugulare; radiosurgery

Year:  2013        PMID: 24436943      PMCID: PMC3836808          DOI: 10.1055/s-0033-1347375

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  13 in total

1.  Gamma Knife radiosurgery of the glomus jugulare tumour - early multicentre experience.

Authors:  R Liscák; V Vladyka; B Wowra; A Kemeny; D Forster; J A Burzaco; R Martinez; S Eustacchio; G Pendl; J Regis; W Pellet
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

2.  Glomus jugulare tumors: effects of radiotherapy.

Authors:  G J Spector; J Compagno; C A Perez; R H Maisel; J H Ogura
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

3.  The safety and efficacy of gamma knife surgery in management of glomus jugulare tumor.

Authors:  Raef F A Hafez; Magad S Morgan; Osama M Fahmy
Journal:  World J Surg Oncol       Date:  2010-09-06       Impact factor: 2.754

4.  Long-term effects of radiation therapy for a catecholamine-producing glomus jugulare tumor. Case report.

Authors:  R M Pluta; Z Ram; N J Patronas; H Keiser
Journal:  J Neurosurg       Date:  1994-06       Impact factor: 5.115

5.  Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients.

Authors:  D Erickson; Y C Kudva; M J Ebersold; G B Thompson; C S Grant; J A van Heerden; W F Young
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 6.  Radiosurgery for glomus jugulare: history and recent progress.

Authors:  Zachary D Guss; Sachin Batra; Gordon Li; Steven D Chang; Andrew T Parsa; Daniele Rigamonti; Lawrence Kleinberg; Michael Lim
Journal:  Neurosurg Focus       Date:  2009-12       Impact factor: 4.047

Review 7.  Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors.

Authors:  Oren N Gottfried; James K Liu; William T Couldwell
Journal:  Neurosurg Focus       Date:  2004-08-15       Impact factor: 4.047

Review 8.  The genetics of paragangliomas.

Authors:  N Burnichon; N Abermil; A Buffet; J Favier; A-P Gimenez-Roqueplo
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2012-10-15       Impact factor: 2.080

9.  A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors.

Authors:  Michael E Ivan; Michael E Sughrue; Aaron J Clark; Ari J Kane; Derick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurosurg       Date:  2010-10-29       Impact factor: 5.115

10.  The role of radiation therapy in the management of catecholamine-secreting glomus tumors.

Authors:  M K Schwaber; G S Gussack; W Kirkpatrick
Journal:  Otolaryngol Head Neck Surg       Date:  1988-02       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.